公司资料
Connect Biopharma Holdings Limited 股价、新闻与催化剂
- 股票代码:
- CNTB
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- China and listed in the U
股票表现
2.49 USD (-2.35%)
收盘价
最后更新: 2026年8月17日
135M USD
市值
股价为何变动
As of Aug 17, 2026, CNTB closed down 2.35% at $2.49. No new same-company headline was identified in the current news window.
公司概览
业务概览
Connect Biopharma is an immunology company focused on inflammatory and autoimmune diseases. Its story is built around developing targeted therapies for chronic immune-mediated conditions.
所在地与行业分类
Connect Biopharma is headquartered in China and listed in the U.S. market. It sits in specialty immunology biotechnology.
商业模式特征
The company depends on clinical data, translational confidence, and the ability to progress a focused inflammatory pipeline. Investors watch efficacy signals and strategic developments.
生物医药行业定位
Connect occupies a niche immunology position within biotech. It is catalyst-sensitive because the market needs evidence that the platform can differentiate in a crowded area.
未来催化剂
- Connect Biopharma’s catalysts are its inflammatory-disease programs, especially any update that clarifies whether the company can still build a credible immunology story. The market will care about human data.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。